Alexandre Netto

Alexandre Netto

Auto-generated profile, based on publicly available information

Alexandre Netto

Protecting Brains & Saving Futures, Clinical Research Department, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2022 in Jornal de Pediatria
Verified
Journal Article
Open access
GVGabriel Fernando Todeschi Variane
Gabriel Fernando Todeschi Variane
DRDaniela Pereira Rodrigues
Daniela Pereira Rodrigues
RPRafaela Fabri Rodrigues Pietrobom
Rafaela Fabri Rodrigues Pietrobom
CFCarolina Nunes França
Carolina Nunes França
ANAlexandre Netto
Alexandre Netto
MMMaurício Magalhães
Maurício Magalhães
Amplitude-integrated electroencephalography (aEEG) is a simplified bedside neurophysiology tool that has been implemented in the neonatal intensive care unit and studied in an extensive range of clinical applications in the past decade. This critical review aimed to evaluate a variety of clinical applications of aEEG monitoring in diagnosis, clinical management, and prognosis assessment in critically ill neonates. The databases of Pubmed, SciELO, Lilacs, and Cochrane, books, and other online resources were consulted, as well as sources of professional experiences. The clinical use of aEEG to access real-time brain function, background activity, and utility in seizures detection has been described. A critical review was realized considering the authors’ professional experience. Newborns with hypoxic-ischemic encephalopathy and seizures screening represent the most common studied population. However, several studies have shown interesting applications on preterm infants, newborns with congenital heart disease, and other clinical situations of high risk of injury to the developing brain. The aEEG has shown to be a useful non-invasive bedside monitor that aids in evaluating brain function, background activity, and cyclicity. aEEG findings have also demonstrated good prognostic value in a group of critically ill neonates. The aEEG seizure diagnosis capability has limitations, which have been already well established. The use of neonatal brain monitoring such as aEEG was shown to give valuable information in several high-risk clinical situations.

12 January 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GVGabriel Fernando Todeschi Variane
Gabriel Fernando Todeschi Variane
MMMaurício Magalhães
Maurício Magalhães
RPRafaela Fabri Rodrigues Pietrobom
Rafaela Fabri Rodrigues Pietrobom
ANAlexandre Netto
Alexandre Netto
DRDaniela Pereira Rodrigues
Daniela Pereira Rodrigues
GSGuilherme Sant'Anna
Guilherme Sant'Anna
Background: Management of high-risk newborns should involve the use of standardized protocols and training, continuous and specialized brain monitoring with electroencephalography (EEG), amplitude integrated EEG, Near Infrared Spectroscopy, and neuroimaging. Brazil is a large country with disparities in health care assessment and some neonatal intensive care units (NICUs) are not well structured with trained personnel able to provide adequate neurocritical care. To reduce this existing gap, an advanced telemedicine model of neurocritical care called Protecting Brains and Saving Futures (PBSF) Guidelines was developed and implemented in a group of Brazilian NICUs. Methods: A prospective, multicenter, and observational study will be conducted in all 20 Brazilian NICUs using the PBSF Guidelines as standard-of-care. All infants treated accordingly to the guidelines during Dec 2021 to Nov 2024 will be eligible. Ethical approval was obtained from participating centers. The primary objective is to describe adherence to the PBSF Guidelines and clinical outcomes, by center and over a 3-year period. Adherence will be measured by quantification of neuromonitoring, neuroimaging exams, sub-specialties consultation, and clinical case discussions and videoconference meetings. Clinical outcomes of interest are detection of seizures during hospitalization, use of anticonvulsants, inotropes, and fluid resuscitation, death before hospital discharge, length of hospital stay, and referral of patients to specialized follow-up. Discussion: The study will provide evaluation of PBSF Guidelines adherence and its impact on clinical outcomes. Thus, data from this large prospective, multicenter, and observational study will help determine whether neonatal neurocritical care via telemedicine can be effective. Ultimately, it may offer the necessary framework for larger scale implementation and development of research projects using remote neuromonitoring. Trial registration: NCT03786497, Registered 26 December 2018, https://www.clinicaltrials.gov/ct2/show/NCT03786497?term=protecting+brains+and+saving+futures&draw=2&rank=1.

23 September 2025 in The Lancet Regional Health - Americas
Verified
Journal Article
Open access
GVGabriel Fernando Todeschi Variane
Gabriel Fernando Todeschi Variane
DLDanieli Mayumi Kimura Leandro
Danieli Mayumi Kimura Leandro
SASilvia Schoenau de Azevedo
Silvia Schoenau de Azevedo
RRRafaela Fabri Rodrigues
Rafaela Fabri Rodrigues
LSLeticia Brito Sampaio
Leticia Brito Sampaio
KMKrisa Page Van Meurs
Krisa Page Van Meurs
Neonatal brain injury is a major global health challenge, disproportionately affecting low- and middle-income countries (LMIC), where access to specialized care remains limited. Technology-driven neuroprotective strategies may allow the dissemination of specialized care to resource-constrained settings. This study describes the implementation of a digital health strategy to deliver specialized neurocritical care to multiple neonatal intensive care units (NICUs) in Brazil. Retrospective observational multicenter cohort study analyzing data from July 2017 to June 2024, from 79 NICUs across Brazil. A digital health strategy was implemented, incorporating real-time video amplitude-integrated and raw electroencephalography (video-aEEG/EEG), near-infrared spectroscopy (NIRS), and vital signs monitoring, supported by neonatology and pediatric neurology experts available 24/7. Education and training of bedside providers were accomplished by initial in-person sessions, followed by online training. An immersive reality tool was piloted to conduct consultations between the central monitoring and bedside teams. 11,333 neonates received neurocritical care with 727,858 h of remotely recorded brain monitoring and 124,967 interactions between monitoring centers and bedside teams. Most neonates were male (57.7%), the median gestational age was 37 weeks (IQR 32–39), and the mean birth weight was 2667 g (SD ± 635 g). The most common neuromonitoring indications were suspected seizures (23.3%), moderate or severe hypoxic-ischemic encephalopathy (15.9%), and mild hypoxic-ischemic encephalopathy (13.3%). In the study population, electrographic seizures were identified in 18.4%, and a single antiseizure medication achieved seizure control in 56.1%. The first line antiseizure medication was phenobarbital (97%). Pathologic aEEG/EEG background pattern was seen in 24.9%, and sleep-wake cycling was absent in 41.2%. Simultaneous video-aEEG/EEG and NIRS monitoring data were acquired from 1688 infants. Immersive reality was successfully piloted in 2023 in a single center, enhancing consultations between central monitoring and bedside teams and standardizing the training of healthcare professionals performing the modified Sarnat exam. Applying digital solutions for specialized neurocritical care and training across distant and resource-limited centers is feasible and has the potential to promote equity and increase quality of care for high-risk infants. None.

6 June 2024 in Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo
Verified
Journal Article
Open access
PDF file
GVGabriel Fernando Todeschi Variane
Gabriel Fernando Todeschi Variane
ANAlexandre Netto
Alexandre Netto
DRDaniela Pereira Rodrigues
Daniela Pereira Rodrigues
DLDanieli Mayumi Kimura Leandro
Danieli Mayumi Kimura Leandro
CFCarolina Nunes França
Carolina Nunes França
MMMarcelo Jenné Mimica
Marcelo Jenné Mimica
Background: Hypoxic-ischaemic encephalopathy (HIE) is a leading cause of long-term disability. Infants with HIE may require specific lifelong care, representing a devastating social and economic impact. Therapeutic hypothermia (TH) has been proven to be a safe and effective treatment; however, its potential economic impact associated with continuous electroencephalographic monitoring is still unknown in Brazil. This study aimed to evaluate the potential economic benefits provided by TH and continuous electroencephalographic monitoring in the first 20 years of life in infants with HIE in Brazil. Methods: A resource utilization questionnaire about healthcare of infants with HIE was answered by 57 pediatricians and neonatologists in all five regions of Brazil. This data was used to calculate an annual weighted average of patient management costs according to the presence or degree of disability, considering only directly related health costs. A mathematical calculation was performed considering local incidence of HIE and the number of live births per year. Rates of death and survival for different levels of disability and the effect of TH on these outcomes were estimated from the two most relevant randomized controlled trials on TH. Results: There was an approximately 26-fold increase in spending when the severe disability group was compared to the no disability group (p-value<0.0001, ANOVA-Bonferroni). The estimated total cost of patients with no disability, mild, moderate, and severe disability is US$ 6,808.53, US$ 32,208.43, US$ 105,791.78 and US$ 175,698.58, respectively, and the estimated costs related to the use of TH and neuromonitoring were estimated in US$ 2,824.00. Considering a weighted average between TOBY trial and NICHD trial, it is estimated annual savings of US$ 39,700,000-79,401,000. Conclusions: This study estimated a significant increase in the costs associated with the degree of disability and a positive impact of TH throughout the first 20 years of life. Keywords: Children with disability, Health care costs, Hypoxic-ischemic encephalopathy, Neonatal intensive care, Therapeutic hypothermia Resumo Introdução: A encefalopatia hipóxico-isquêmica (EHI) é uma das principais causas de deficiência incapacitante a longo prazo. Recém-nascidos (RN) com EHI podem necessitar de cuidados específicos ao longo da vida, representando um impacto social e econômico devastador. A hipotermia terapêutica (HT) é comprovadamente um tratamento seguro e eficaz; entretanto, seu potencial impacto econômico associado ao monitoramento eletroencefalográfico contínuo ainda é desconhecido no Brasil. Este estudo tem como objetivo avaliar os potenciais benefícios econômicos proporcionados pela HT e pela monitorização eletroencefalográfica contínua nos primeiros 20 anos de vida em lactentes com EHI no Brasil. Métodos: Um questionário de utilização de recursos sobre cuidados de saúde de crianças com EHI foi respondido por 57 pediatras e neonatologistas das cinco regiões do Brasil. Esses dados foram usados para calcular uma média anual ponderada dos custos de cuidados de saúde destes pacientes de acordo com a presença ou grau de incapacidade, considerando apenas custos de saúde diretos. Um cálculo matemático foi realizado considerando a incidência local de EHI e o número de nascidos vivos por ano. As taxas de mortalidade e de sobrevivência para diferentes níveis de incapacidade e o efeito da HT nestes resultados foram estimados a partir dos dois ensaios clínicos randomizados e controlados mais relevantes sobre a HT. Resultados: Houve um aumento de aproximadamente 26 vezes nos gastos quando o grupo com deficiência grave foi comparado ao grupo sem deficiência (p-valor<0,0001, ANOVA-Bonferroni). O custo total estimado para os pacientes sem incapacidade, com incapacidade leve, moderada e grave é de US$ 6.808,53, US$ 32.208,43, US$ 105.791,78 e US$ 175.698,58, respetivamente, e os custos estimados relacionados ao uso da HT e da neuromonitoramento foram estimados em US$ 2.824,00. Considerando uma média ponderada entre o estudo TOBY e o estudo NICHD, estima-se uma economia anual de US$ 39.700.000-79.401.000. Conclusões: Este estudo estimou um aumento significativo dos custos associados ao grau de incapacidade e um impacto positivo da HT ao longo dos primeiros 20 anos de vida. Palavras-chave: Crianças com deficiência, Custos de cuidados de saúde, Encefalopatia hipóxica-isquêmica, Terapia intensiva neonatal, Hipotermia induzida